General
Will the US FDA approve the first male birth control pill or gel for commercial sale before the end of 2029?
A health and science prediction on a long-awaited breakthrough in reproductive health equity.
96 total votes
Analysis
Male Birth Control: On the Shelf by 2029?
Clinical trials for male contraceptives (like the hormonal gel NES/T or non-hormonal pills like YCT-529) have advanced to Phase 2. This prediction asks if a product will receive full FDA approval for commercial sale by 2029.
The Safety Bar
The slight 'No' majority reflects the exceptionally high safety bar for male contraceptives. Since men do not bear the physical risks of pregnancy, the FDA requires a side-effect profile near zero for approval. Phase 3 trials are massive, expensive, and slow. While the science works, the regulatory timeline often stretches a decade. 2029 is a best-case scenario, with the early 2030s being a more conservative estimate for widespread availability.